This article was originally published in SRA
Proposals to relax entry regulations and widen pharmacy services
You may also be interested in...
Indivior aims to cut costs by restructuring its US commercial operations and reducing discretionary spending, in order to improve flexibility in the face of the COVID-19 pandemic and to invest in R&D.
Look! Up in the sky! It’s a bird! It’s a plane! It’s … a COVID-19 test from Quest Diagnostics.
New directors at 4D Pharma, Neurogene And Zogenix.